Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04055272 · ClinicalTrials.gov registry record · NA
A Mobile Text Messaging Intervention for Indoor Tanning Addiction
A NA study of Indoor Tanning, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 265
- Enrollment target
- 1
- Study location
NCT04055272: Completed NA study of Indoor Tanning, sponsored by Georgetown University.
NCT04055272 is a NA study of Indoor Tanning that has completed, run by Georgetown University. The registered enrollment target is 265 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04055272, a NA study of Indoor Tanning, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 265 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the effects of messages communicating the risks (i.e., health harms, addictiveness) of indoor tanning delivered via mobile text messaging among young adult women ages 18 to 30 years who meet screening criteria for indoor tanning addiction.
Primary Outcome
Motivation to quit is measured by participant report by a single question with a 1 to 7 response scale. Higher scores indicate greater motivation to quit and are considered better outcomes. This question is administered at 1 month follow up and at 3 month follow up.
Conditions Studied
Interventions
- BEHAVIORAL Mobile text messaging intervention
Study Locations (1)
District of Columbia
- Georgetown University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 265 participants |
| Start Date | 2020-01-07 |
| Est. Completion | 2022-03-31 |
| Phase | NA |
What the finished NCT04055272 record still lists
NCT04055272 is an interventional study that assigns participants to a tested intervention. The registered 265 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Indoor Tanning appearing as the primary indexed condition, and to 1 intervention - of which Mobile text messaging intervention is the first listed.
NCT04055272 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04055272 about?
NCT04055272 is a clinical study titled "A Mobile Text Messaging Intervention for Indoor Tanning Addiction". The purpose of this study is to test the effects of messages communicating the risks (i.e., health harms, addictiveness) of indoor tanning delivered via mobile text messaging among young adult women ages 18 to 30 years who meet screening criteria for indoor tanning addiction.
What is the current status of trial NCT04055272?
This trial is currently completed. It is a NA study. The enrollment target is 265 participants. The study started on 2020-01-07. Estimated completion is 2022-03-31.
What conditions does trial NCT04055272 study?
This clinical trial studies the following conditions: Indoor Tanning.
What interventions are being tested in trial NCT04055272?
The interventions under investigation include: Mobile text messaging intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04055272?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04055272 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04055272's enrollment target sits among peer trials
265 395th of 2000 higher than 1,606 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443126 · 265 participants · Phase 1
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
- NCT05470491 · 265 participants · Phase 1
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
- NCT07301905 · 265 participants · NA
Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI
- NCT07470853 · 265 participants · Phase 1
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI